GxPReady! is a biotechnology startup founded in 2012 and based in the United States. The company offers validated, cost, and time-efficient SaaS CMMS solutions compliant with FDA 21CFR11 and EMA Annex 11 requirements. Targeting regulated small to medium companies globally, GxPReady provides a reliable VALIDATED WEB-BASED CMMS for asset management. The suite includes calibration, validation, and maintenance management, offering a FREE trial with the option to convert to a validated status. The company boasts features such as 21CFR11/Annex 11 compliance included in pricing, no hardware/software installation, and patented Flash Validation™ on a Qualified Private Cloud. With a focus on affordability and ease of use, GxPReady offers a modern solution for businesses needing validated calibration, maintenance, and validation tracking systems. The company provides pricing details and facilitates free demo requests through their website. For further inquiries, GxPReady can be contacted via email or phone. This startup presents an attractive opportunity for investment with its niche focus and innovative approach to compliance and asset management.
There is no investment information